dexcom glp-1 Benefits of using CGM with drugs for diabetes treatment GLP-1 and Dexcom G7 CGM:

Learn how to support metabolic health from a functional nutrition lens.

GLP-1 is the hormone targeted by Ozempic to reduce appetite and promote satiety

body composition, nutrient levels, and metabolic markers are critical in determining treatment and possible tapering.Not everyone needs to take GLP-1s forevertapering is possible, but it depends on individual health markers, genetics, and whether metabolic signals are balanced.The future of metabolic health lies in combination therapies that target multiple pathways, not just GLP-1s.Dieting alone disrupts metabolic signals, making professional metabolic medicine and nutrition guidance essential for long-term health.Resources:Connect with Dr

Compared with diabetic patients who did not use GLP-1 RAs having an incidence of 12.85 per 1000 person-years, the adjusted hazard ratio (HR) of DR was 0.42 [95% confidence interval (CI), 0.290.61]

(lf you use the patchovernight,remave it the next moming.) Safety Warning Please keep out of reach of children

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment